
Portage Biotech Granted Additional Time to Meet Stock Exchange Listing Obligations
Portage Biotech Receives Notification of Compliance Extension from Nasdaq Dover, Del., Feb. 12, 2025 – Portage Biotech, Inc. (Portage or the Company), a clinical-stage immuno-oncology company, recently announced that it has received notification from The Nasdaq Stock Market, LLC (Nasdaq) that the exchange has accepted the Company’s compliance plan and granted an extension to regain…